Geographical tongue induced by axitinib.
作者信息
Sundar Santhanam, Burge Frances
机构信息
Department of Oncology, University Of Nottingham, Nottingham, UK.
Department of Urology, Sherwood Forest NHS Trust, Sutton-in-Ashfield, UK.
出版信息
BMJ Case Rep. 2015 Oct 16;2015:bcr2015211318. doi: 10.1136/bcr-2015-211318.
Abstract
摘要
相似文献
1
Geographical tongue induced by axitinib.阿昔替尼诱发的地图舌。
BMJ Case Rep. 2015 Oct 16;2015:bcr2015211318. doi: 10.1136/bcr-2015-211318.
2
Axitinib.阿昔替尼
Prescrire Int. 2013 Nov;22(143):262-3.
3
Reversible posterior leukoencephalopathy syndrome induced by axitinib.阿昔替尼诱发的可逆性后部白质脑病综合征
Clin Genitourin Cancer. 2014 Feb;12(1):e33-4. doi: 10.1016/j.clgc.2013.08.008. Epub 2013 Oct 14.
4
Axitinib-related osteonecrosis of the jaw.阿昔替尼相关的颌骨坏死。
Oral Surg Oral Med Oral Pathol Oral Radiol. 2017 Nov;124(5):e257-e260. doi: 10.1016/j.oooo.2017.08.003. Epub 2017 Aug 18.
5
Axitinib-induced acute pancreatitis: a case report.阿昔替尼致急性胰腺炎：病例报告。
Anticancer Drugs. 2014 Apr;25(4):478-9. doi: 10.1097/CAD.0000000000000076.
6
Thyroid dysfunction in patients treated with tyrosine kinase inhibitors, sunitinib, sorafenib and axitinib, for metastatic renal cell carcinoma.酪氨酸激酶抑制剂（舒尼替尼、索拉非尼和阿昔替尼）治疗转移性肾细胞癌患者的甲状腺功能障碍。
Jpn J Clin Oncol. 2012 Aug;42(8):742-7. doi: 10.1093/jjco/hys076. Epub 2012 May 23.
7
[Axitinib in metastatic renal carcinomas: update of knowledge about side effects].阿昔替尼治疗转移性肾癌：副作用相关知识更新
Bull Cancer. 2014 Oct;101(10):976-88. doi: 10.1684/bdc.2014.2042.
8
[Dysthyroidism with anti-VEGF treatment, a class effect? about one case report].
Therapie. 2014 Nov-Dec;69(6):521-4. doi: 10.2515/therapie/2014063. Epub 2014 Oct 9.
9
Cutaneous Vasculopathy as an Adverse Effect of the Anti-Vascular Endothelial Growth Factor Agent Axitinib.
JAMA Dermatol. 2016 Feb;152(2):222-3. doi: 10.1001/jamadermatol.2015.3209.
10
Inappropriate elevation of serum thyrotropin levels in patients treated with axitinib.阿昔替尼治疗患者的血清促甲状腺激素水平升高不适当。
Thyroid. 2013 Apr;23(4):443-8. doi: 10.1089/thy.2012.0378.
引用本文的文献
1
Clinical Characteristics and Risk Factors of Geographic Tongue: A Retrospective Analysis of 100 Polish Patients.地图舌的临床特征及危险因素：对100例波兰患者的回顾性分析
Healthcare (Basel). 2025 May 29;13(11):1299. doi: 10.3390/healthcare13111299.
2
Drug-induced Tongue Disorders: A Comprehensive Literature Review.药物性舌部疾病：一篇综合文献综述
Curr Drug Saf. 2025;20(2):148-213. doi: 10.2174/0115748863299971240513061630.
3
Angiogenesis Inhibitor Drug-induced Benign Migratory Glossitis in a Patient of Juvenile-onset Recurrent Respiratory Papillomatosis under Maintenance Therapy.血管生成抑制剂药物诱发的青少年复发性呼吸道乳头状瘤病维持治疗患者的良性游走性舌炎
Int J Clin Pediatr Dent. 2024 Jan;17(1):92-96. doi: 10.5005/jp-journals-10005-2739.
4
Pathogenesis of Oral Toxicities Associated with Targeted Therapy and Immunotherapy.靶向治疗和免疫治疗相关口腔毒性的发病机制。
Int J Mol Sci. 2023 May 3;24(9):8188. doi: 10.3390/ijms24098188.
5
Bevacizumab-Induced Geographic Tongue.贝伐单抗诱发的地图舌。
Dermatol Pract Concept. 2021 Jul 8;11(3):e2021043. doi: 10.5826/dpc.1103a43. eCollection 2021 Jul.
本文引用的文献
1
Geographic tongue induced by angiogenesis inhibitors.血管生成抑制剂诱发的地图舌。
Oncologist. 2013;18(4):e16-7. doi: 10.1634/theoncologist.2012-0320. Epub 2013 Apr 10.
2
Characteristics of oral mucosal events related to bevacizumab treatment.与贝伐珠单抗治疗相关的口腔黏膜事件的特征。
Oncologist. 2012;17(2):274-8. doi: 10.1634/theoncologist.2011-0198. Epub 2012 Jan 26.
Zotero 插件